» Articles » PMID: 35157510

Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage

Abstract

Purpose: The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized in the literature. Review of how existing pediatric cancer clinical trial groups internationally have been formed and how their research goals have been pursued is critical for building global collaborative research and data-sharing efforts, in line with the WHO Global Initiative for Childhood Cancer.

Methods: A narrative literature review of collaborative groups performing pediatric cancer clinical research in each continent was conducted. An inventory of research groups was assembled and reviewed by current pediatric cancer regional and continental leaders. Each group was narratively described with identification of common structural and research themes among consortia.

Results: There is wide variability in the structure, history, and goals of pediatric cancer clinical trial collaborative groups internationally. Several continental regions have longstanding endogenously-formed clinical trial groups that have developed and published numerous adapted treatment regimens to improve outcomes, whereas other regions have consortia focused on developing foundational database registry infrastructure supported by large multinational organizations or twinning relationships.

Conclusion: There cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.

Citing Articles

Building RECOVERY: development of the registry of eating disorders and their co-morbidities OVER time in youth.

Richmond T, Farbman Kadish E, Santoso M, Milliren C, Kells M, Woolverton G J Eat Disord. 2024; 12(1):147.

PMID: 39334287 PMC: 11430501. DOI: 10.1186/s40337-024-01097-7.


Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group.

Li C, Kurkure P, Arora R, Chen B, Kirgizov K, Okamoto Y JCO Glob Oncol. 2023; 9:e2300153.

PMID: 37656946 PMC: 10581612. DOI: 10.1200/GO.23.00153.


How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?.

Bailey S, Davidson A, Parkes J, Tabori U, Figaji A, Epari S JCO Glob Oncol. 2022; 8:e2200156.

PMID: 36252166 PMC: 9812475. DOI: 10.1200/GO.22.00156.

References
1.
Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L . Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge. J Clin Oncol. 2015; 33(27):3065-73. PMC: 4979198. DOI: 10.1200/JCO.2014.60.6376. View

2.
Lopes L, Macedo C, Pontes E, Aguiar S, Mastellaro M, Melaragno R . Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. J Clin Oncol. 2009; 27(8):1297-303. DOI: 10.1200/JCO.2008.16.4202. View

3.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-1075. PMC: 5879496. DOI: 10.1016/S0140-6736(17)33326-3. View

4.
Howard S, Davidson A, Luna-Fineman S, Israels T, Chantada G, Lam C . A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP). Pediatr Blood Cancer. 2018; 64 Suppl 5. DOI: 10.1002/pbc.26879. View

5.
Koshinaga T, Takimoto T, Oue T, Okita H, Tanaka Y, Nozaki M . Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG). Pediatr Blood Cancer. 2018; 65(7):e27056. DOI: 10.1002/pbc.27056. View